Of note, available data from publicly available genome‐wide CRISPR‐Cas9 genetic screens also confirmed that several human BRAF-mutant melanoma cell lines (https://depmap.org/ceres/) (17, 18) are sensitive to DUSP4 depletion. This evidence concerns the gene BRAF and melanoma.